June 24: The Week in Cancer News
American Cancer Society reacts to Supreme Court decision, and more from the week in cancer news.
Progress Against Cancer
American Cancer Society reacts to Supreme Court decision, and more from the week in cancer news.
The CAR T-cell therapy lisocabtagene maraleucel was approved for the second-line treatment of certain patients with large B-cell lymphoma. The U.S. Food and Drug Administration (FDA) has approved lisocabtagene maraleucel (Breyanzi) for the second-line...
Ibrutinib, a small molecule inhibitor of B-cell proliferation, was approved for pediatric patients with chronic graft-versus-host disease. The U.S. Food and Drug Administration (FDA) has approved ibrutinib (Imbruvica) for pediatric patients 1 year of...
The FDA approved a combination of two kinase inhibitors for the treatment of solid tumors bearing the BRAF V600E mutation. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to the kinase...
Clinical trials rebound after COVID-19 setbacks, and early treatment leads to significant reduction in anal cancer risk among people with HIV.
Factors associated with the imaging facility, rather than individual characteristics, may explain some of the differences the accuracy of mammograms across racial and ethnic groups.
A new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.
Since COVID-19 first began its siege on the world, much of our scientific knowledge about the disease—and its source virus, SARS-CoV-2—has changed and evolved. One thing that has remained clear, however, is that cancer...
Patients who lose weight through bariatric surgery have a lower cancer risk, and a HER2-targeted therapy gets striking results in HER2-low breast cancer patients.
Contrast dye shortage delays scans for cancer, and more public assistance linked to higher survival rates for Black cancer patients.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More